1. Banks, Emily, Francis, Vincent, Lin, Sheng-Jia, Rudko, David A, McPherson, Peter S. 2024. Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy. In Nature communications, 15, 7239. doi:10.1038/s41467-024-51310-z. https://pubmed.ncbi.nlm.nih.gov/39174524/
2. Yang, Muyi, Johnsson, Per, Bräutigam, Lars, Cao, Yihai, Höiom, Veronica. 2021. Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma. In Genetics in medicine : official journal of the American College of Medical Genetics, 24, 157-169. doi:10.1016/j.gim.2021.09.003. https://pubmed.ncbi.nlm.nih.gov/34906508/
3. Banks, Emily, Francis, Vincent, Lin, Sheng-Jia, Rudko, David A, McPherson, Peter S. 2024. Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy. In medRxiv : the preprint server for health sciences, , . doi:10.1101/2022.08.23.22278845. https://pubmed.ncbi.nlm.nih.gov/38352438/
4. Li, Yaping, Xu, Jianing, Xiong, Huan, Dalton, Stephen, Zhao, Shaying. 2014. Cancer driver candidate genes AVL9, DENND5A and NUPL1 contribute to MDCK cystogenesis. In Oncoscience, 1, 854-865. doi:. https://pubmed.ncbi.nlm.nih.gov/25621300/
5. Anazi, S, Maddirevula, S, Faqeih, E, Shaheen, R, Alkuraya, F S. 2016. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield. In Molecular psychiatry, 22, 615-624. doi:10.1038/mp.2016.113. https://pubmed.ncbi.nlm.nih.gov/27431290/
6. Yin, Shulei, Li, Chunzhen, Zhang, Yunyan, Hu, Han, Li, Tianliang. 2024. A Novel Tumor-Associated Neutrophil-Related Risk Signature Based on Single-Cell and Bulk RNA-Sequencing Analyses Predicts the Prognosis and Immune Landscape of Breast Cancer. In Journal of Cancer, 15, 5655-5671. doi:10.7150/jca.100338. https://pubmed.ncbi.nlm.nih.gov/39308692/
7. Liu, Gao-Lei, Luo, Hao, Liang, Dan-Dan, Dai, Nan, Lan, Wei-Hua. 2024. Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Tumor Immune Infiltration in Bladder Cancer. In Recent patents on anti-cancer drug discovery, , . doi:10.2174/0115748928329276241020184935. https://pubmed.ncbi.nlm.nih.gov/39473202/